Last reviewed: June 29, 2026
Last updated: June 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The question of how overweight you need to be to qualify for semaglutide therapy is more nuanced than a single number on a scale. Clinical studies show that GLP-1 receptor agonists produce meaningful weight loss across diverse populations, with the FDA approving semaglutide for weight management in adults with a body mass index (BMI) of 30 or higher, or 27 or higher with weight-related health conditions. However, individual eligibility extends beyond BMI alone and depends on your complete health picture.
Understanding BMI Thresholds for GLP-1 Weight Loss Therapy
Body Mass Index serves as a starting point for determining GLP-1 candidacy, though it's not the only factor PlexusDx evaluates. A BMI of 30 or above places you in the obese category, where semaglutide shows robust clinical benefits. The cutoff of 27 applies when you also have weight-related conditions such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea. These comorbidities indicate that weight loss could meaningfully improve your overall health outcomes and disease management.
BMI calculations divide your weight in pounds by your height in inches squared, then multiply by 703. For example, a person 5'9" tall with a BMI of 30 weighs approximately 220 pounds. However, BMI doesn't account for muscle mass, bone density, or where fat is distributed on your body, which is why clinical assessment matters alongside the number.
Weight-Related Health Conditions That Expand Eligibility
Having a BMI between 27 and 30 opens semaglutide access if you carry a weight-related diagnosis. Type 2 diabetes dramatically increases cardiovascular risk, making weight loss a critical intervention—semaglutide addresses both blood sugar control and weight reduction simultaneously. Hypertension, elevated triglycerides, and prediabetes also qualify as conditions where weight management directly impacts treatment outcomes and medication burden.
Sleep apnea, arthritis, and fatty liver disease represent additional weight-related conditions that physicians consider when evaluating GLP-1 candidacy. Losing even 5-10% of body weight can reduce sleep apnea severity, decrease joint stress, and improve liver function. PlexusDx reviews your complete health history to determine whether semaglutide aligns with your clinical needs, regardless of whether your BMI strictly meets the 30 threshold.
How Semaglutide Works Across Different Starting Weights
Semaglutide activates GLP-1 receptors in your brain, reducing hunger signals and increasing feelings of fullness with smaller meal portions. This mechanism operates similarly whether you weigh 220 pounds or 320 pounds, though individual response varies based on genetics, lifestyle, and metabolic factors. Clinical trials demonstrate average weight loss of 5-15% of body weight over 68 weeks, with some patients achieving reductions exceeding 20%.
The peptide also slows gastric emptying—the rate at which food leaves your stomach—creating prolonged satiety signals that help you eat less without constant willpower. Weight loss compounds over months as you maintain a calorie deficit through naturally reduced appetite rather than restrictive dieting. PlexusDx compounded semaglutide injections start at $149 per month, making this mechanism accessible without insurance or membership fees.
Beyond BMI: Other Factors PlexusDx Considers for GLP-1 Candidacy
Age, kidney function, thyroid history, and personal or family history of medullary thyroid cancer influence semaglutide eligibility and dosing strategy. Older adults may benefit from GLP-1 therapy but require careful monitoring, while those with severe kidney disease need dose adjustments. PlexusDx evaluates your medical records and current medications to ensure semaglutide won't interact harmfully with your existing treatment plan.
Pregnancy status, gallbladder health, and history of pancreatitis also factor into the decision-making process. Women planning pregnancy should discuss GLP-1 timing with their provider, as the medication is typically discontinued three months before attempting conception. The Precision Peptide Genetic Test—available as a $99 add-on after your first month—identifies genetic variants in pathways like GLP1R (rs6923761) and MC4R (rs17782313) that predict your individual response to semaglutide therapy, personalizing your treatment approach.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I have to be at least 300 pounds to qualify for semaglutide?
No. Semaglutide eligibility depends on BMI and health conditions, not absolute weight. You may qualify with a BMI as low as 27 if you have type 2 diabetes, hypertension, or another weight-related condition. PlexusDx evaluates your complete health picture during your consultation to determine candidacy.
What does clinical evidence say about semaglutide effectiveness across different starting weights?
FDA trials show semaglutide produces 5-15% body weight reduction on average regardless of starting weight, with results driven by BMI reduction rather than absolute pounds lost. Patients with higher starting weights often achieve larger absolute weight losses, though percentage reductions tend to cluster in similar ranges across the BMI spectrum.
What does PlexusDx semaglutide cost if I don't have insurance?
PlexusDx compounded semaglutide injections start at $149 per month with no insurance required and no membership fees. Your dose may need to go up—your price won't. HSA and FSA accounts are accepted for additional savings.
Is compounded semaglutide as safe as brand-name Ozempic?
PlexusDx sources semaglutide exclusively from licensed 503A compounding pharmacies, which operate under strict FDA oversight and quality standards. Compounded medications undergo the same sterility, potency, and purity testing as brand formulations, though compounded versions are not FDA-approved as finished drugs.
How does the Precision Peptide Genetic Test help predict my semaglutide response?
The test analyzes 14 pathways and 150+ genetic insights, including GLP1R variants that influence receptor sensitivity and FTO variants linked to appetite regulation. Understanding your genetic predispositions helps PlexusDx personalize your semaglutide dosing and identify whether combination therapy might benefit you better. The test costs $99 as an add-on after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic and Nausea: Why Does Ozempic Make You Throw Up After Eating?
Optimizing Your Ozempic Journey: When is the Best Time to Take an Ozempic Shot?